Background Oral bisphosphonate use has been associated with a small risk of developing
oral osteonecrosis that occurs spontaneously or after the patient has undergone dental …

OBJECTIVE: To determine whether use of oral bisphosphonates is associated with an
increased risk of aseptic osteonecrosis (AON) among a cohort of elderly cardiovascular …

Prior studies have associated raloxifene and strontium ranelate with deep venous
thromboembolism and pulmonary embolism. In a cohort study, we observed an increased …

Although case reports of adverse events with osteoporosis medications suggest potential
links, epidemiological analyses have largely failed to illuminate a strong, clear link between …

BACKGROUND Intravenous bisphosphonate therapy has been linked to osteonecrosis of
the jaw among patients with cancer. Some patients with osteoporosis also receive …

We describe a case of acute nongranulomatous anterior uveitis associated with alendronate
therapy, in an adult woman, without medical history of previous diseases, except for …

PURPOSE: It is well known that oral bisphosphonates can induce necrosis of the osseous
structures of the jaws. However, there seems to be a limited awareness that oral …

Bisphosphonates are used to inhibit bone absorption as a treatment for hypercalcemia
associated with osteolytic bone cancer, bony metastasis, Paget disease, and osteoporosis …

Treatments for postmenopausal osteoporosis are generally safe, but are linked to some rare
serious adverse drug reactions, for which causality is not always certain. The …

BACKGROUND: Bisphosphonates are used to fight osteoporosis and for treating
malignancies. In 2003, the first case reports appeared that described bisphosphonate …